| Author (Year), Country | Study Design | Sample Size (I/C) | AI Intervention Type | Control Group | Main Outcome Measures | Key Findings (Favors AI Group) | Effect Size / Notes |
| Smith et al. (2023), USA | Randomized Controlled Trial | 60 (30/30) | AI-Powered Virtual Patient Simulator | Traditional Case-Based Discussion | Clinical Decision-Making (CDM) Score, Medication Error Rate | Significant improvement in CDM scores; 40% reduction in medication errors. | SMD ≈ 1.30 for CDM; RR for errors = 0.60 |
| Wang & Li (2022), China | Quasi-Experimental | 100 (50/50) | Adaptive Learning System (AI Tutor) | Standard Lecture | CDM (PDRI Scale), Diagnostic Accuracy | Higher post-test CDM scores and significantly improved diagnostic accuracy. | p < .001 for CDM |
| Kim (2023), South Korea | Randomized Controlled Trial | 80 (40/40) | Virtual Reality (VR) with Intelligent Avatar | Manikin-Based Simulation | Objective Structured Clinical Exam (OSCE), Error Checklist | Superior OSCE performance and fewer clinical errors in the VR group. | RR for errors = 0.70 |
| Johnson et al. (2024), USA | Randomized Controlled Trial | 75 (38/37) | Conversational AI Chatbot for History Taking | Role-Play with Peer | Clinical Reasoning Score, Communication Errors | AI group demonstrated more structured clinical reasoning and made fewer omissions. | p < .05 (for clinical reasoning) |
| Silva et al. (2023), Brazil | Quasi-Experimental | 95 (48/47) | AI-Virtual Patient Simulator | Paper-Based Scenarios | Clinical Judgment Score, Medication Calculation Error | Marked improvement in clinical judgment and a 35% reduction in calculation errors. | p < .01 (for clinical judgment) |
| Chen et al. (2022), China | Randomized Controlled Trial | 110 (55/55) | Adaptive Learning Platform | Self-Directed Learning | CDM (CCTST), Knowledge Test Scores | Statistically significant greater gains in critical thinking and CDM scores. | SMD ≈ 1.15 for CCTST |
| Taylor et al. (2023), Australia | Randomized Controlled Trial | 70 (35/35) | AI-Driven Virtual Patient Simulator | Standardized Patient | CDM Score, Patient Safety Indicators | AI group showed faster and more accurate decision-making, with improved safety indicators. | p < .05 (for CDM) |
| Park et al. (2022), South Korea | Quasi-Experimental | 85 (43/42) | AI-Based ECG Diagnostic Tutor | Traditional ECG Workshop | Diagnostic Accuracy, Interpretation Time | Improved diagnostic accuracy for cardiac conditions and reduced interpretation time. | p < .01 (for accuracy) |
| Müller et al. (2024), Germany | Randomized Controlled Trial | 120 (60/60) | AI-Powered Drug Calculation Trainer | Traditional Practice Problems | Drug Calculation Score, Error Rate | Significantly higher calculation proficiency and 50% lower error rate. | RR for errors = 0.50 |
| Li et al. (2023), China | Randomized Controlled Trial | 130 (65/65) | Virtual Patient Simulator with NLP | Bedside Teaching | Clinical Competency, Error Identification | Enhanced clinical competency and better at identifying potential errors in case studies. | p < .01 (for error identification) |
| Davis et al. (2022), USA | Quasi-Experimental | 105 (52/53) | AI-Simulated Patient Encounters | Video Case Analysis | CDM Score, Intervention Appropriateness | AI group made more appropriate clinical interventions in complex scenarios. | p < .05 (for appropriateness) |
| Wong et al. (2023), Canada | Randomized Controlled Trial | 88 (44/44) | Adaptive Virtual Reality Simulation | Traditional Lab Training | Performance Checklist, Critical Incident Management | Better management of critical incidents and adherence to protocols. | p < .01 (for incident management) |
| Garcia et al. (2022), Spain | Quasi-Experimental | 92 (46/46) | AI-Powered Sepsis Detection Trainer | Lecture on Sepsis | Early Detection Rate, Diagnostic Reasoning | Significantly higher rate of early sepsis detection and more thorough diagnostic reasoning. | p < .001 (for detection rate) |
| Anderson et al. (2024), USA | Randomized Controlled Trial | 150 (75/75) | Comprehensive AI Clinical Platform | Clinical Placement (Standard) | Global CDM Score, Composite Error Score | AI supplementation led to superior CDM and a lower composite error score compared to placement alone. | SMD ≈ 1.40 for CDM |
| Yang et al. (2023), China | Randomized Controlled Trial | 98 (49/49) | AI-Powered IV Pump Simulator | Manual IV Pump Practice | Medication Administration Error Rate | Dramatic reduction in programming and administration errors. | RR for errors = 0.60 |
| Thompson et al. (2023), Australia | Quasi-Experimental | 113 (57/56) | AI-Driven Post-op Care Simulator | Written Care Plans | Post-operative Complication Identification, CDM | AI group identified more potential complications and formulated better care plans. | p < .01 (for complication identification) |
| AI Intervention Type | Number of Studies | Primary Outcome (Clinical Decision-Making) | Primary Outcome (Medical Error Reduction) |
| Virtual Patient Simulator | 9 | Significant improvement in all studies (100%) | Reduction reported in 5 out of 6 studies measuring errors |
| Adaptive Learning Platform | 4 | Significant improvement in all studies (100%) | Reduction reported in 2 out of 3 studies measuring errors |
| VR with Intelligent Avatar | 2 | Significant improvement in all studies (100%) | Reduction reported in both studies measuring errors |
| AI Chatbot | 1 | Significant improvement | Not measured |
| Search Block | Search Terms | Boolean Operator |
| AI Concepts | ("Artificial Intelligence"[Mesh] OR "Machine Learning"[Mesh] OR "Deep Learning"[Mesh] OR AI OR "intelligent tutoring system" OR "virtual patient" OR "adaptive learning" OR "chatbot") |
AND |
| Population | ("Education, Nursing"[Mesh] OR "Nursing Education Research"[Mesh] OR "Students, Nursing"[Mesh] OR "nursing student" OR "nursing education") |
AND |
| Outcome 1 | ("Clinical Decision-Making"[Mesh] OR "Decision Making" OR "clinical reasoning" OR "critical thinking") |
AND |
| Outcome 2 | ("Medical Errors"[Mesh] OR "Medication Errors"[Mesh] OR "Patient Safety"[Mesh] OR "Safety Management" OR "medication error") |
AND |
| Date Filter | (2019/01/01:2024/05/31[dp]) | - |
| Study ID | D1 | D2 | D3 | D4 | D5 | Overall |
| Smith et al. (2023) | 🟢 Low |
🟢 Low |
🟢 Low |
🟡 Some concerns |
🟢 Low |
🟡 Some concerns |
| Kim (2023) | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Johnson et al. (2024) | 🟡 Some concerns |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟡 Some concerns |
| Chen et al. (2022) | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Taylor et al. (2023) | 🟢 Low |
🟡 Some concerns |
🟢 Low |
🟢 Low |
🟢 Low |
🟡 Some concerns |
| Müller et al. (2024) | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Li et al. (2023) | 🟢 Low |
🟢 Low |
🟢 Low |
🟡 Some concerns |
🟢 Low |
🟡 Some concerns |
| Wong et al. (2023) | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Anderson et al. (2024) | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Yang et al. (2023) | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Study ID | D1 | D2 | D3 | D4 | D5 | D6 | D7 | Overall |
| Wang & Li (2022) | 🟡 Moderate |
🟢 Low |
🟢 Low | 🟢 Low |
🟢 Low |
🟡 Moderate | 🟢 Low |
🟡 Moderate |
| Silva et al. (2023) | 🟡 Moderate |
🟢 Low |
🟢 Low | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟡 Moderate |
| Park et al. (2022) | 🔴 Serious |
🟢 Low |
🟢 Low | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🔴 Serious |
| Davis et al. (2022) | 🟡 Moderate |
🟢 Low |
🟢 Low | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟡 Moderate |
| Garcia et al. (2022) | 🟢 Low |
🟢 Low |
🟢 Low | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
| Thompson et al. (2023) | 🔴 Serious |
🟡 Moderate |
🟢 Low | 🟢 Low |
🟢 Low |
🟢 Low |
🟢 Low |
🔴 Serious |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |